http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2423972-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4346225143055292dd711f4516199f7e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-06
filingDate 2009-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8dacbc626df8939e19bf16f85e4c4cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f5cd3427481f27b82cdca21cecc5902
publicationDate 2011-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2423972-C1
titleOfInvention Method of conservative treatment of hyperactive urinary bladder in children taking into account its daily activity
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to children's urology, and can be intended for conservative treatment of hyperactive urinary bladder in 14-17 year old children. For this purpose introduced is m-anticholinergic "spasmex" in dose 2 mg/year of life, one time per day, in the morning, during 1 month. n EFFECT: method makes it possible to increase efficiency of conservative treatment and reduce daily activity of hyperactive urinary bladder by creation of maximal concentration of medicine in organism. n 1 ex
priorityDate 2009-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452510108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452510107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034812

Total number of triples: 17.